Navigation Links
Regulus to Present at Two Upcoming Investor Conferences
Date:2/4/2013

LA JOLLA, Calif., Feb. 4, 2013 /PRNewswire/ -- Regulus Therapeutics Inc. (NASDAQ: RGLS), a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today announced that Kleanthis G. Xanthopoulos , Ph.D., President and CEO of Regulus, will present a company overview at the 15th Annual BIO CEO & Investor Conference on Tuesday, February 12, 2013 at 1:00 pm EST.  Dr. Xanthopoulos will also present at the Leerink Swann Global Healthcare Conference on Wednesday, February 13, 2013 at 3:00 pm EST.  The conferences are being held at the Waldorf-Astoria Hotel in New York City.

Each presentation will be webcast at the time of the presentation and can be accessed on the Investor Relations page of the Company's website at www.regulusrx.com.  A replay of each webcast will be archived on the Company's website for two weeks following the presentation date.

About Regulus

Regulus Therapeutics Inc. (NASDAQ: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs.  Regulus is leveraging a mature therapeutic platform based on technology that has been developed over 20 years. Regulus works with a broad network of academic collaborators and leverages the oligonucleotide drug discovery and development expertise of its founding companies, Alnylam Pharmaceuticals and Isis Pharmaceuticals. Regulus is advancing microRNA therapeutics toward clinical development in several areas, including oncology, fibrosis, hepatitis C and metabolic diseases. Regulus has formed strategic alliances with AstraZeneca, GlaxoSmithKline and Sanofi and a research collaboration with Biogen Idec.

For more info
'/>"/>

SOURCE Regulus Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Regulus Therapeutics Forms Strategic Alliance for Discovery, Development and Commercialization of microRNA Therapeutics with AstraZeneca
2. Biogen Idec and Regulus Therapeutics Form Collaboration to Explore microRNA Biomarkers for Disease Monitoring and Response to Therapy
3. Regulus Presents New Preclinical Data on miR-21 at Kidney Week 2012
4. Regulus Announces $80.9 Million in Total Gross Proceeds from IPO and Other Recent Financial Transactions
5. Regulus Appoints Douglas E. Williams, Ph.D. to its Board of Directors
6. Regulus Announces Timing for Third Quarter 2012 Financial Results Webcast and Conference Call
7. Regulus Reports Third Quarter 2012 Financial Results and Recent Highlights
8. Regulus Appoints Mark G. Foletta to its Board of Directors
9. Report Presents a Framework for Successful New Oncology Product Launches in the Pharmaceutical Sector
10. Latest Findings in Breastfeeding Science Presented at Medelas 7th International Breastfeeding and Lactation Symposium
11. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... and NEW YORK , October 1, 2014 ... Organization (CRO) and service provider for the medical industries, announced today ... offices in New York City . genae Americas ... is strategically centered in one of the highest concentrations ... said Philippe Kassab , President at genae Americas. "The expansion ...
(Date:10/1/2014)... , Oct. 1, 2014  Express Scripts (NASDAQ: ... available 2015 Express Scripts Medicare ® Prescription Drug ... featuring Walgreens (NYSE: WAG ) (NASDAQ: ... choice and clinical support  for their Medicare dollars. ... Medicare Value or Choice plans ...
(Date:10/1/2014)... 2014  CVS Health is thanking its 26,000 pharmacists ... changing the way health care is delivered to increase ... retail pharmacies, mail service pharmacies and specialty pharmacies nationwide.  ... name to CVS Health to reflect our broader health ... needed to shape the future of health," said ...
Breaking Medicine Technology:genae Opens Offices in New York City 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 2Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 3Express Scripts Collaborates with Walgreens to Create Value-Driven Medicare Prescription Drug Plan Pharmacy Network 4CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 2CVS Health Thanking its Pharmacists during American Pharmacists Month for Helping People on Their Path to Better Health 3
... Announces Positive Data in Animal Models of ... /PRNewswire-FirstCall/ -- Callisto,Pharmaceuticals, Inc. , a developer ... cancer and other major health threats, announced,today ... compound currently being developed for the treatment,of ...
... Journal of Cell Science Shows ONCONASE Uptake in,Cells ... 2007 /PRNewswire-FirstCall/ --,Alfacell Corporation today announced that European ... to enter,cells. , Published in the Journal of ... studies conducted at the University of Girona in,Spain ...
Cached Medicine Technology:Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis 2Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis 3Callisto Intends to Move Guanilib into Clinical Trials in,Ulcerative Colitis 4Researchers Identify Intracellular Pathway of Alfacell's Onconase 2Researchers Identify Intracellular Pathway of Alfacell's Onconase 3
(Date:10/1/2014)... brain of a rat and a robot could revolutionise ... leading robotics researcher. , Dr Michael Milford from ... uses new computer algorithms to enable robots to navigate ... is a very Frankenstein type of project," Dr Milford ... together because we,re taking the eyes of a human ...
(Date:10/1/2014)... suggests the adage that encourages people to keep their ... it comes to exercise. When walking, staying focused on ... it appear shorter and help people walk there faster, ... technique to walking while looking around the environment naturally, ... exercise. , "People are less interested in exercise if ...
(Date:10/1/2014)... 01, 2014 Bedros Keuilian is not ... Camp fitness boot camps, he’s also considered the leading ... with sold out business summits, a line of high-demand ... to a recent Spike TV reality show to his ... is the time for personal trainers and fitness business ...
(Date:10/1/2014)... and ATLANTA (PRWEB) October 01, 2014 ... security executive networking and relationship-marketing firm, announced ... Information Security Executive® and Project of the ... top-ranking decision makers representing organizations in financial ... Projects include large-scale technology endeavors that address ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 Beverly Hills ... Kathleen Mojas is celebrating 20 years of private practice ... hundreds of people to achieve greater joy and fulfillment ... list of warning signs and suggestions for anyone who ... Mojas explains: “Believe it or not, it’s not ...
Breaking Medicine News(10 mins):Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 2Health News:Keeping your eyes on the prize can help with exercise, NYU study finds 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 2Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 3Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 4Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 5Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 6Health News:T.E.N. Announces Nominees for the 2014 ISE® North America Awards; People’s Choice Award voting now open to industry at large 7Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 2Health News:Prominent Beverly Hills Psychologist Dr. Kathleen Mojas Celebrating 20 Years in Private Practice Identifies Common Warning Signs That You May Be In a Toxic Relationship. 3
... , , JACKSONVILLE, Fla., ... network, today announced the expansion of its existing partnership with ... include secure real-time eligibility and benefits transactions at no charge ... relationship between Availity and WellCare for health care claims transactions, ...
... FORT LAUDERDALE, Fla., Aug. 25 OmniComm Systems, Inc. ... data capture (EDC) solutions for clinical trials, announced today ... Pleiad, Inc., a Cambridge, Massachusetts based Contract Research Organization ... eClinical services to its customers. Pleiad,s investment will provide ...
... , , LOUISVILLE, Colo., Aug. ... Plastic and Reconstructive Surgery Journal , the official journal ... been clinically proven to be a safe and effective treatment ... University demonstrated VASER Lipo to be an enhanced fat removal ...
... Serrated colorectal polyps include the subgroups hyperplastic polyps, sessile ... adenomas. Recent studies have found that serrated polyps share ... to the hypothesis that serrated polyps can be precursors ... to cancer sequence. These cancers tend to arise in ...
... , , , INDIANAPOLIS , ... its selection as one of LATINA Style magazine,s "Top Twelve Companies ... in the magazine,s 50 Report. More than 800 companies were considered ... Style magazine is an acknowledgment that our mission to improve the ...
... say , TUESDAY, Aug. 25 (HealthDay News) -- A ... tumors has been identified by German researchers. , The ... cancer and compared them with healthy breast tissue. The ... of GLI1 (glioma-associated oncogene homolog 1) protein tended to ...
Cached Medicine News:Health News:Availity Provides Real-Time Access to WellCare 2Health News:Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider 2Health News:Pleiad Devices Selects OmniComm Systems as their eClinical Solutions Provider 3Health News:New Study Reveals VASER(R) Lipo to be the New Standard of Care for Body Contouring and Fat Transfer Procedures 2Health News:New Study Reveals VASER(R) Lipo to be the New Standard of Care for Body Contouring and Fat Transfer Procedures 3Health News:Reinterpretation of proximal colon polyps called hyperplastic in 2001 2Health News:WellPoint Named a Top Place to Work by LATINA Style Magazine 2Health News:WellPoint Named a Top Place to Work by LATINA Style Magazine 3Health News:Protein May Identify Deadlier Breast Cancer 2
... High performance Tecoflex stents that save inventory, ... Stents accommodate ureteral lengths from 22 cm ... allows the Quadra-Coil to glide over any ... These stents provide ease of placement and ...
... drainage from the ureteropelvic junction to the ... ease of placement and patient compliance. The ... repositioning and ease of removal. AQ® is ... when activated, attracts and holds water and ...
The CMV IgM enzyme immunoassay is for the qualitative detection of antibodies to cytomegalovirus. The CMV IgM assay is primarily indicated for the detection of early or recent infection....
The Shandon Sequenza uses the Shandon Coverplate system which ensures consistency and excellent staining quality. , , ,Allows the user to perform large immunostaining runs (up to 50 slides/run...
Medicine Products: